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The Structure and Mechanism of the Type II
Dehydroquinase from Streptomyces coelicolor
catalyzes the third step of the shikimate pathway, dehy-
dration of 3-dehydroquinate to 3-dehydroshikimate (Fig-
ure 1). This step is common to the catabolic quinate
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John R. Coggins,2 and Adrian J. Lapthorn1,5 pathway, which converts quinic acid to p-hydroxyben-
zoic acid that can be further metabolised via the -keto-1Department of Chemistry and
2 Division of Biochemistry and Molecular Biology adipate pathway to acetyl-CoA and succinyl-CoA [6, 7].
Two classes of DHQases have been described: theInstitute of Biomedical and Life Sciences
University of Glasgow type I enzyme, which is associated exclusively with
chorismate biosynthesis in fungi, plants, and some bac-Glasgow G12 8QQ
Scotland teria, and the type II enzyme, which is found in the
quinate pathway of fungi and in the shikimate pathwayUnited Kingdom
3 Department of Bioscience and Biotechnology of many bacteria. The two classes of enzymes operate
by entirely different mechanisms, as exemplified by theUniversity of Strathclyde
Glasgow G1 1XW contrasting stereochemistry of the reactions catalyzed
[8]. Type I enzymes catalyze a syn elimination of waterScotland
United Kingdom with the loss of the pro-R hydrogen from C2 [9, 10], and
the mechanism involves an imine intermediate [11, 12].4 University Chemical Laboratory
University of Cambridge Type II enzymes catalyze an anti elimination reaction
with the loss of the more acidic axial pro-S hydrogenLensfield Road
Cambridge CB2 1EW from C2, which is thought to proceed via an enolate
intermediate [13, 14]. Recently, representative crystalUnited Kingdom
structures of both types of enzyme have been deter-
mined [15], confirming that the enzymes are structurally
unrelated and possess different folds. The SalmonellaSummary
typhi type I enzyme has an / barrel structure and is
dimeric, while the Mycobacterium tuberculosis type IIThe structure of the type II DHQase from Streptomyces
enzyme has a flavodoxin-like fold and forms a dode-coelicolor has been solved and refined to high resolu-
camer with tetrahedral symmetry [15].tion in complexes with a number of ligands, including
In this paper we report the amino acid sequence,dehydroshikimate and a rationally designed transition
purification, crystallization, and the determination of astate analogue, 2,3-anhydro-quinic acid. These struc-
number of structures of the type II DHQase from Strepto-tures define the active site of the enzyme and the role
myces coelicolor. These structures permit a detailedof key amino acid residues and provide snap shots of
description of the active site, which includes the pre-the catalytic cycle. The resolution of the flexible lid
viously unobserved loop (residues 22–29) that closesdomain (residues 21–31) shows that the invariant resi-
over the active site pocket and allow us to assign func-dues Arg23 and Tyr28 close over the active site cleft.
tions to individual amino acid residues in the proposedThe tyrosine acts as the base in the initial proton ab-
mechanism. In addition, the structure of the enzymestraction, and evidence is provided that the reaction
in complex with a transition state analog includes aproceeds via an enol intermediate. The active site of
molecule of tartrate and glycerol in the active site, pro-the structure of DHQase in complex with the transition
viding a structural basis for the development of inhibi-state analog also includes molecules of tartrate and
tors by rational design.glycerol, which provide a basis for further inhibitor de-
sign.
Results and Discussion
Introduction The Enzyme Fold
The type II DHQase from S. coelicolor is assembled
The shikimate pathway is a central biosynthetic route from 12 identical monomers of 156 amino acid residues
using erythrose 4-phosphate and phosphoenol pyruvate (molecular mass of 16,541 Da) to form a dodecamer.
to produce chorismate, the precursor for the synthesis The monomer (Figure 2) is an / protein with a central
of aromatic amino acids, folic acid, ubiquinone, and five-stranded parallel  sheet with a strand order of
many other aromatic compounds. This pathway is found 21345, which is a flavodoxin-like fold, as defined in the
in bacteria, higher plants, and fungi [1, 2] and has been SCOP classification of protein folds [16]. There are four
recently discovered in apicomplexan parasites [3]. Its main  helices in the structure, with 1 and 4 on one
absence from mammals has made this pathway an at- face of the  sheet and 2 and the 3 on the other. The
tractive target for the development of herbicides [4] and
3 helix is interrupted at Ser87, which leads to a change
antimicrobial agents [5]. The enzyme 3-dehydroquinate in its direction. The two parts of this helix are referred
dehydratase or dehydroquinase (DHQase; EC 4.2.1.10)
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Figure 1. Dehydration of 3-Dehydroquinate
(1) to Form 3-Dehydroshikimate (2) and Struc-
ture of the Transition State Analog 2,3-Anhy-
dro-Quinic Acid (3)
to as 3 and 3″. In addition to the  helices, there are that the 20 C-terminal amino acids of type II DHQase
contain three conserved glycines with the sequence Gly-four short stretches of 310 helix, labeled H1–H4. H1 is
located between  strand 1 and helix 1, and the other X-Gly-X-X-Gly and a number of hydrophobic residues
similar to the NAD binding motif [17]. From the crystalthree segments of 310 helix are found in a 23-amino acid
sequence between  strands 4 and 5. structure, it can be seen that this region of the
S. coelicolor type II DHQase adopts a structure similarThe primary structures of type II DHQase are strongly
conserved, with 17% of residues invariant and a further to the first part of an NAD binding motif, although this
does not extend to the remainder of this region. NAD47% conserved over the 19 sequences shown in Figure
3. The enzyme shares no significant sequence similarity binding domains contain this Gly-X-Gly-X-X-Gly se-
quence at their N terminus (20–30 residues), but thiswith any other group of proteins, and there is not suffi-
cient structural similarity with other flavodoxin-like pro- often follows a substrate binding domain, as in alcohol
dehydrogenase. It is tempting to speculate that the typeteins to suggest common ancestry. It has been noted
II DHQase has arisen from the truncation of such a dehy-
drogenase, with the fragment of the NAD binding motif
acquiring an alternative function.
The Quaternary Structure
The S. coelicolor type II DHQase, like the M. tuberculosis
enzyme [15], is dodecameric. On forming the dode-
camer, each monomer buries 2041 A˚2 of solvent-acces-
sible surface, which corresponds to 30% of the total
monomer surface area. The dodecamer has tetrahedral
23-point group symmetry and is roughly spherical in
shape, with a diameter of 100A˚ (Figure 4). This is the
simplest form of cubic symmetry but has only previously
been seen in the structures of ornithine carbamoyltrans-
ferase from Pseudomonas aeruginosa [18] and Pyrococ-
cus furiosus [19]. In the dodecamer there are essentially
two interfaces: a trimer interface, formed by two dissimi-
lar surfaces lying parallel to the plane of the  sheet,
and a symmetric dimer interface, formed by the continu-
ation of the  sheets through two monomers (Figure
4B). Studies of the unfolding and refolding of type II
DHQase [20] have shown that the trimer is the minimum
catalytic unit of the enzyme. The dodecamer can thus
be considered as a tetramer of trimers.
In forming the trimer, each monomer buries 1320 A˚2,
or 20%, of its solvent-accessible area at two surfaces.
If we consider a single subunit within the trimer, subunit
Figure 2. A Ribbon Representation of the Monomer of S. coelicolor A, this buries 673 A˚2 (surface 1), predominantly from
DHQase helices 2 and 3, at the interface with subunit B. The
 helices (cyan) are labeled 1–4, 310 helices (purple) are labeled loops and helices at the C-terminal end of the parallel 
H1–H4, and  strands (green) are labeled 1–5. The lid domain sheet of subunit A also bury 647 A˚2 of solvent-accessible
that is disordered in the M. tuberculosis structure [15] is also labeled.
area (surface 2) at the interface with subunit C (FigureThe ligand 2,3-anhydro-quinic acid is shown in ball and stick repre-
5B). There are seven hydrogen bonds and one saltsentation to highlight the position of the active site. The diagram
was produced using the program RIBBONS [42]. bridge formed at each interface, and an equal distribu-
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Figure 3. A Sequence Alignment of Type II DHQases from Representative Prokaryotic and Eukaryotic Organisms
 helices and  strands are represented as helices and arrows, respectively, and  turns are marked TT. The first row under the aligned
sequences highlights those amino acid residues buried at the dimer interface (cyan) and the trimer interface, surface 1 (green) and surface 2
(orange). Some amino acid residues are buried at both the dimer and trimer interfaces (magenta) or at both trimer interfaces (yellow). Key
residues in the active site are marked with blue triangles; those responsible for catalysis are marked with red asterisks. The sequence alignment
was created using ESPript [43] and the following sequences (organism, Genebank/Swissprot accession in parenthesis): AROQ_STRCO
(S. coelicolor, P15474), AROQ_CAUCR (Caulobacter crescentus, AAK23857), AROQ_SYNY3 (Synechocystis sp., P73367), 3DHQ_EMENI (Emeri-
cella nidulans, P05147), AROQ1_PSEAE (Pseudomonas aeruginosa, AF010322), AROQ2_PSEAE (P. aeruginosa, AAG03634), AROQ_VIBCH
(Vibrio cholerae, AAF93471), AROQ_MYTUB (M. tuberculosis, P36918), AROQ_CLOAC (Clostridium acetobutylicum, AAK78875), AROQ_HELPY
(Helicobacter pylori, Q48255), AROQ_THEMA (Thermotoga maritima, Q9WYI4), and AROQ_DEIRA (Deinococcus radiodurans, P54517). Open
reading frames (ORF) from the incomplete genome sequences were obtained from The Institute for Genomic Research website at http://
www.tigr.org for PORGI (Porphyromonas gingivalis), GEOSU (Geobacter sulfurreducens), and BACAN (Bacillus anthracis) and from the Sanger
Centre Sequencing Project website at http://www.sanger.ac.uk/Projects/ for BORPE (Bordetella pertussis) and YERPE (Yersinia pestis), and
preliminary sequence data was obtained from The DOE Joint Genome Institute (JGI) at http://www.jgi.doe.gov/JGI_microbial/html/index.html
for RHOSP (Rhodobacter sphaeroides) and SYNSP (Synechococcus sp.).
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by the central  sheet (Figure 4B). On one side of the
interface, residues in the final turn and terminal helix
(4) of the two subunits pack against each other and
against Gly128 and Val130 of strand 5 to bury approxi-
mately 50% of a predominantly hydrophobic surface
(Figure 5A). The residues on the other side of the  sheet
form a much more hydrophilic surface, which includes
a significant solvent-accessible cavity formed between
the three 310 helices H2–H4. Histidine 111 makes the
largest single contribution (83 A˚2) to the buried surface
area at the dimer interface. The two imidazole rings of
the dimer-related histidines point toward each other,
effectively restricting the size of the solvent cavity and
leaving a doughnut-shaped space, which is occupied
by water.
The Active Site
The active site in type II DHQase is located in the cleft
formed at the carboxy edge of the  sheet between
strands 1 and 3, which is common not only to en-
zymes with a flavodoxin-like fold but also to / struc-
tures in general [22]. This cleft is partially closed off by
interaction with helix 3 of the neighboring subunit at
the trimer interface (residues from this subunit will be
marked with an asterisk), specifically by the formation
of a salt bridge between Arg117 and Asp92*. A flexible
loop (residues 21–31) forms a lid, which closes over
the active site on binding substrate; this includes the
residues Arg23 and Tyr28, previously identified as being
catalytically important [23].
The initial crystallizations of S. coelicolor DHQase
were carried out in the presence of 200 mM sodium
phosphate, which has been shown to be a competitive
inhibitor of the type II enzyme from A. nidulans [24]. This
structure revealed a phosphate ion bound in the active
site forming H bonds with ND1 of His106, ND2 of Asn79,
OH of Tyr28, OG of Ser108, and the backbone nitrogens
of Ile107 and Ser108; the remainder of the active site
cavity is occupied by nine water molecules (Figure 6B).
The position of the phosphate ion is surprising, as it
was assumed that a negative ion would mimic binding
of the carboxylate group of dehydroquinate and interact
with an arginine (either Arg23 or Arg113), as has been
Figure 4. Two Views of the Dodecamer of DHQase in a Ribbon seen in the type I DHQase [15]. Subsequent structures
Representation of both the wild-type enzyme in complex with a transition
Each chain is colored uniquely and phosphate ions are in CPK state analog, 2,3-anhydro-quinic acid [25], and of an
representation to show the position of the active site. inactive DHQase mutant R23A [23] complexed with
(A) A view down the NCS 3-fold axis with the catalytic trimer in front
product (DHS, dehydroshikimate) show conclusivelyclearly visible (chain A, cyan; chain B, gold; chain C, magenta). The
that the phosphate binds in the carboxylate binding siteother side of the NCS 3-fold axis is a large open cavity with no
(Figure 6). The carboxylate binding loop is formed fromtrimer interactions.
(B) The dodecamer viewed down the NCS 2-fold axis between the main chain amide nitrogens of residues 107–108 and
chains E (light green) and L (blue). The other two NCS 2-folds are the side chain of OH of Ser108 and ND2 of Asn79 (Figure
perpendicular and can clearly be seen to run diagonally through the 6C) and forms a significant part of the substrate recog-
dodecamer in this view.
nition.
Asn79 is invariant and is held in place in the active
site by hydrogen bonds to its side chain from the amidetion of polar and nonpolar atoms at both of these two
surfaces. N of Ala81 to OD1 and from the OH hydroxyl of Tyr138
to ND2. In addition to its role in binding the carboxylate,At the dimer interface, each monomer buries 795 A˚2
of solvent-accessible surface to form an interface that the side chain OD1 is positioned to act as the hydrogen
bond acceptor for the C1 hydroxyl of the substrate, asis flat, with a length of 30 A˚ and a breadth of 25 A˚, and
composed of approximately equal numbers of polar seen in 2,3-anhydro-quinic acid structure (Figure 6D).
Histidine 106 is therefore the hydrogen bond donor toand nonpolar atoms [21]. The interface brings together
equivalent regions of each subunit, which are separated the C1 hydroxyl, and this is consistent with it coordi-
Structure and Mechanism of Type II DHQase
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Figure 5. A Surface and Ribbons Represen-
tation of the Dimer and Trimer Interfaces
(A) The surface buried of chain A at the dimer
interface, colored according to the descrip-
tion in the text, illustrating the hydrophobic
surface on one side (dark blue) and the hydro-
philic surface on the other (green).
(B) Chains A and B and associated surfaces
have been rotated to expose the two different
surfaces (surface 1 and 2, respectively) bur-
ied at the trimer. A ribbon representation of
chain A (green) and chain B (blue), with resi-
dues (colored by atom type) contributing to
the buried surface area shown in stick; key
residues are labeled for clarity. Surface 1 is
colored according to residue ranges: resi-
dues 15–24, orange; residues 57–59, ma-
genta; residues 82–86, green; residues 113–
117, cyan). Surface 2 is blue, except for
residues that also contribute to surface 1,
which are colored accordingly.
The figure was produced using the program
GRASP [44].
nating to the phosphate ion. The proposed role for all of the structures reported here and hydrogen bonded
to ND2 of Asn16.this invariant residue is somewhat counterintuitive, as
His106 also hydrogen bonds with another invariant resi- A key difference between the S. coelicolor DHQase
structures reported here and the M. tuberculosisdue, Glu104, to form a histidine-glutamate pair similar
to the residues (His143 and Glu86) implicated in the DHQase structure [15] is the presence of an ordered lid
domain (residues 21–31) in which residues 25–28 adoptmechanism of the type I DHQase [15].
The six-membered ring of the substrate and product an -helical structure. There is a significant hinged
movement at residues Gly21 and Asp31, resulting in alie on the floor of the active site, which is formed from
the carboxy end of strand 3 and helix 3 (residues movement of over 5 A˚ between complexed and apo
structures (Figure 7A). Further evidence for flexibility is79–85). The residues at positions 81 and 82 are highly
conserved as either alanine or glycine, due, in part, to provided by the main chain conformational changes at
Arg23 and Gly29. This structurally characterizes the li-steric restrictions in the case of residue 82, which is
almost totally buried at the trimer interface close to the gand-induced conformational change proposed pre-
viously from proteolysis and chemical modification ex-Asp92*-Arg117 intrasubunit salt bridge. These residues
form an extended conformation, with their planar pep- periments [17]. When closed, the lid domain forms a
loop that extends over the carboxy edge of strands 3tide bonds giving rise to a flat surface with which the
ligands interact. and 4 of the central sheet and interacts with helix 3
of a trimer-related subunit. In this orientation the sideThe unambiguous identification of the C4 and C5 hy-
droxyls was possible in the R23A mutant DHS structure chain of Tyr28 is positioned into the active site with the
hydroxyl, forming an H bond to the guanidino group ofdue to the high resolution of the X-ray data. Averaged
omit maps show clearly the pucker in the ring system, Arg113. The other invariant residue, Arg23, is not as well
ordered in all structures but is not orientated toward thethe C4 hydroxyl oriented down, and the C5 hydroxyl
oriented up, as found in the 2,3-anhydro-quinic acid active site. In the complex with phosphate, Arg23 adopts
an unusual conformation, packing against the ring ofstructure. The C4 and C5 hydroxyl groups are important
for substrate recognition, with the C5 hydroxyl of both the tyrosine, while, in the apo structure and in the com-
plex with 2,3-anhydro-quinic acid, it forms a salt bridge2,3-anhydro-quinic acid and DHS interacting with NE2
of His 85 and NH1 of Arg117. Arg117 forms a salt bridge with Asp98 on the trimer-related subunit.
with Asp92 from the neighboring subunit. This aspartate
forms the major interaction with the C4 hydroxyl of the Enzyme Mechanism
The first step of the proposed mechanism involves ab-substrate through OD2. The carbonyl at C3 is only pres-
ent in the mutant dehydroshikimate structure and forms straction of the pro-S proton from the C2 carbon of
dehydroquinate. It has previously been suggested that aa hydrogen bond to a water molecule that is found in
Structure
498
histidine (His106 in this structure) would have its basicity
elevated as it forms a His-Glu pair with Glu104 and could
act as the base toward the substrate [15]. The structure
of the enzyme complexed with 2,3-anhydro-quinic acid
unambiguously shows that His106 interacts with the C1
hydroxyl and does not have a role in proton abstraction.
Comparing the various structures of type II DHQase
reported here, it is apparent that the only residue in the
correct orientation for proton abstraction is the invariant
residue Tyr28 (Figure 8). The hydroxyl of free tyrosine
has a pKa of 10.0 and therefore would be expected to
be fully protonated at pH 7.0; therefore, the pKa of Tyr
28 must be significantly shifted by its environment in
the enzyme. The proximity of Arg113 and, to a lesser
extent, Arg23 would be expected to have a significant
effect on the pKa of Tyr218, as has been shown in other
proteins, such as human aldose reductase [26].
Abstraction of the pro-S proton from C2 of the sub-
strate would lead to a transition state with a double bond
between C2 and C3 and the carbonyl at C3 presumably
forming an enolate [14]. A basic residue would be
needed to stabilize the enolate, but no residue is suffi-
ciently close to perform this role. Analysis of all the
structures reveals a conserved water molecule that is
2.8 A˚ away from the carbonyl of DHS and held in specific
orientation by hydrogen bonds to an invariant residue,
Asn16, the carbonyl of Pro15, and the main chain amide
of Ala81. Whether or not the enolate obtains a solvent-
derived proton to form an enol is debatable. On forma-
tion of an enol/enolate intermediate, the next step (re-
moval of the hydroxyl at C1) is clearly brought about by
His106 acting as the proton donor (Figure 8). The OD2 of
Asn79 is a hydrogen bond acceptor for the C1 hydroxyl,
thereby correctly orienting it to accept a proton. The
role of the invariant Glu104 (data not shown) in the mech-
anism is unclear; from the structures, it can be seen
that, in addition to hydrogen bonding to the imidazole
of His106, the side chain of Glu104 hydrogen bonds to
Ser120 and Ser123. It might be suggested, therefore,
that Glu104 plays a structural role; however, in the prod-
uct-bound form of the R23A mutant enzyme, Glu104 no
longer forms a hydrogen bond with His106, resulting in
the observed greater flexibility of this residue in the
structure. It is possible that Glu104 has a role in the
correct orientation of His106 for catalysis and must also
move to permit the loss of water from the active site via a
solvent-accessible cavity leading to the dimer interface
(Figure 7B).
phosphate, and (C) complexed with 2,3-anhydro-quinic acid (tartrate
and glycerol labeled) and (D) the Arg23Ala mutant enzyme with
dehydroshikimate (the carbon atoms numbered in magenta). In the
2,3-anhydro-quinic acid structure, glycerol and tartrate molecules
present in the active site are shown (hydrogen bonds omitted for
clarity). The glycerol is bound in a hydrophobic patch formed by
residues Leu17, Leu20, and Tyr28 and forms hydrogen bonds to
Figure 6. A Detailed View of the Active site, with Key Residues the carbonyl of Asn16, a carboxylate of tartrate, and several waters.
Labeled and Hydrogen Bonds  3.2 A˚ in Length Shown as Dashed The molecule of tartrate forms extensive hydrogen bond contacts
Lines with the protein, including electrostatic interactions between Arg23
The electron density shown is 12-fold averaged difference density, and one of the carboxylates and Arg113 and the other carboxylate.
calculated after one round of refinement with all the active site The tartrate also forms hydrogen bonds from one of the hydroxyls
waters and ligands removed. These omit maps show the active sites to the side chains of Asp92 and Asn95 and a short contact from
of the DHQase (A) in the absence of ligand, (B) complexed with one of the carboxylate oxygens to the hydroxyl of Tyr28 (2.1 A˚).
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this apo-enzyme, Arg113 and His85 will give the active
site a suitable net positive charge, which will be impor-
tant for the binding of the substrate.
On binding to the substrate, the lid closes over the
active site via a hinged movement between Gly21 and
Asp31, as seen in the structures of the phosphate and
inhibitor complexes. In addition to this hinged move-
ment, there are significant changes in the main chain
conformation involving Arg23 and Gly29, which are also
a source of mobility in this loop. The result is effectively
to close the active site and bring Tyr28 from over 10 A˚
away into a position to abstract the C2 axial proton. A
catalytic role for this tyrosine had been indicated by the
inactivation of the enzyme by tetranitromethane, which
was shown to modify Tyr28 specifically [23].
The presumed orientation of Tyr28 for proton abstrac-
tion is not seen in any of the structures reported here.
In the 2,3-anhydro-quinic acid complex, it is 3.44 A˚ away
from C2, and, in the phosphate structure, it is 3.0 A˚
from C2. It is clear from these structures that, on ligand
binding, Arg113 forms a hydrogen bond with Ser108, posi-
tioning the guanidinium group to interact with the hydroxyl
of Tyr28. This is not sufficient in itself for the correct
positioning of the hydroxyl, as illustrated by the R23A
mutant structure. In this structure the side chain of Tyr28
is shifted over 4 A˚ away from C2 in comparison to the
structures of the complexes with phosphate and the
inhibitor 2,3-anhydro-quinic acid. Reassessment of site-
directed mutagenesis results, obtained for R23 on the
S. coelicolor enzyme [23], suggests that the replacement
of Arg23 by smaller residues, regardless of charge, re-
sults in Tyr28 adopting an alternative conformation,
more favorable than the one required for catalysis. The
inactive conformation of the lid domain in the R23A
mutant (the enzyme activity of this mutant is reduced
by four orders of magnitude compared to that of the
wild-type) is significantly more ordered on the basis of
the temperature factors than the lid domains from the
Figure 7. A Cartoon Representation of the Movement in the Flexible other 3 structures.
Lid Domain Harris et al. [14] have shown an unusual pH depen-
The inhibitor structure 2,3-anhydro-quinic acid represented in ball dence of type II DHQases for the A. nidulans and M.
and stick, and the corresponding lid domain in dark green. The two
tuberculosis enzymes, in which kcat increases sharplyconformations of the lid domain seen in the apo structure are colored
above pH 8 with a corresponding increase in the Km.in red and mauve.
This led to the suggestion that the catalytic deprotona-(B) A view along the central  sheet of the dimer illustrating a large
solvent-accessible cavity formed in the hydrophilic face of the dimer, tion was carried out by a histidine, with its basicity medi-
calculated using SURFNET [45], is shown in blue, and associated ated by an arginine. As the pH increases, this leads to
water molecules are shown as red spheres. The residue His106, the a reduced charge on arginine, thereby increasing the
general acid involved in the removal of the hydroxyl at C1, is shown
basicity of the histidine. From the structures reportedin both monomers to illustrate the proximity of this cavity to the
here, it is clear that this explanation is broadly correct,active site of the protein.
albeit with a tyrosine, Tyr28, as the residue that performs
the proton abstraction, its pKa mediated by the proxim-
Discussion ity of the side chain of Arg113 and possibly Arg23.
As a result of proton abstraction, it has been sug-
The four structures reported give an insight into some gested that the substrate forms an enolate intermediate,
of the changes that occur during enzyme catalysis. In the with the double bond formed between C2 and C3 intro-
structure of the apo-enzyme, the lid loop is orientated in ducing an element of planarity into the six-membered
an “open” conformation, away from the active site in two ring. The 2,3-anhydro-quinic acid inhibitor mimics this
quite distinct conformations, with the change in position proposed transition state, and it has been shown that
of Tyr28 being especially notable (Figure 7A). In the inhibitors with a double bond between C2 and C3 bind
active site there are five ordered water molecules, two significantly more tightly than those lacking this bond
occupying the carboxyl binding loop, two binding to the [25]. Although the carbonyl at C3 of the substrate is
histidines that coordinate the C1 and C5 hydroxyls, and, presumed to form an enolate intermediate, there is no
amino acid residue close enough to stabilize the nega-finally, the conserved water that is bound to Asn16. In
Structure
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Figure 8. A Schematic Diagram of the Proposed Mechanism of Type II DHQases
tive charge. Instead, a conserved water molecule is cor- intermediate rather than an enolate would need to be
formed. The second proton would come from the subse-rectly positioned 2.8 A˚ away from this group, which, in
turn, coordinates to the ND2 of Asn15, the carbonyl of quent elimination step, where the histidine acting as the
general acid would have a proton readily exchangablePro14, and main chain amide of Ala82. From previous
kinetic isotope studies [14] undertaken on the A. nidu- with the solvent at the pH (7.0) at which the experiments
were carried out.lans and M. tuberculosis enzymes in the absence of
structural data, it was concluded that the data were The final step in catalysis is the acid-catalyzed elimi-
nation of the C1 hydroxyl. It is clear from the crystalconsistent with an enolate rather than an enol formed
during catalysis. In the light of the structures presented structures of the enzyme complexed with 2,3-anhydro-
quinic acid and the R23A mutant complexed with DHShere, it is now possible to better interpret the kinetic
data, particularly the large solvent isotope effect seen that His106 acts as the general acid, with Asn79 cor-
rectly positioning the C1 hydroxyl to accept a proton.for the A. nidulans enzyme, which suggested that two
protons contribute to the kinetically significant transition On elimination, there is a conformational change in the
product as the C1 becomes planar; however, there isstates. Only one water molecule is present in the active
site, and, for it to contribute to an isotope effect, an enol insufficient space at the active site for a water molecule
Table 1. Crystollographic and Structure Determination Statistics
Data Collection
WT Plus 2,3-Anhydro-
Data Set WT Apo WT Plus Phosphate R23A Plus DHS Quinic Acid
Wavelength (A˚) 0.870 0.870 0.870 0.870
Space group P212121 P212121 P21 P212121
Unit cell dimensions (a, b, and c in A˚) 116.2, 138.4, 141.2 113.2, 137.4, 140.2 86.1, 136.2, 96.7 113.6, 138.4, 141.5
Resolution range (A˚) 30.0–1.8 45.0–1.8 45.0–1.6 30.0–1.8
Observations 429,534 798,417 426,136 648,516
Unique reflections 145,400 199,361 213,906 202,189
Completeness (highest resolution shell) 94.5% (93.5%) 98.7% (93.5%) 73.8% (21.5%f ) 98.1% (90.9%)
Rmergea (%) 5.7 5.3 6.4 8.8
Refinement Statistics
Resolution range (A˚) 24.0–2.0 45.0–1.8 45.0–1.6 22.0–1.8
R factorb (Rwork/Rfree) 19.9/24.2 14.9/20.3 17.8/21.2 14.9/19.1
Number of atomsc 13,327/32/1741 13,827/112/2023 13,572/176/1581 13,576/368/2635
Rms bond length deviation (A˚) 0.018 0.018 0.019 0.019
Rms bond angle deviation () 2.0 1.8 1.9 1.8
Mean B factor (A˚)d 18/19/—/32 20/22/26/37 11/13/17/29 8/10/7/28
Rms backbone deviation (A˚) 1.1 0.9 0.7 0.7
Coordinate error (A˚)e 0.250 0.252 0.124 0.120
Intrasubunit average rms deviation (A˚) 0.114 0.222 0.185 0.118
a Rmerge  |I  	I
|/	I
.
b R factor  |Fo  Fc|/Fo.
c Number of atoms of protein, heteroatoms, and water molecules, respectively.
d Mean B factor for main chain, side chain, inhibitor, and water atoms, respectively.
e Calculated using the method of Cruickshank [46].
f Data were processed to the edge (corners) of the CCD detector leading to a drop of in completeness above 1.8 A˚ resolution (76% complete).
Structure and Mechanism of Type II DHQase
501
usage of Streptomyces genes [28]. This 38-mer (5-GGCAACGCCCand the product to be present at the same time. This
C(CG)ATCATGATCCTGAACGGC-CC(CG)AACCT) identified a 3.2 kbmay be a driving force for the release of product, but,
HindIII-SstI fragment in genomic Southern blots, which was clonedadditionally, there is a solvent cavity accessible to
into pIBI25 [29]. The resulting plasmid was called pDHQ. The region
His106 through the dimer interface (Figure 7B). This cav- around the site of hybridization by the oligonucleotide was se-
ity arises from the small size of residues such as Ser123, quenced manually by the dideoxy termination method. It has been
deposited in the EMBL database with the accession numberVal129, and Ala131, which are conserved over most type
AJ001493. The construction of the R23A mutant enzyme has beenII DHQase sequences, suggesting that the release of
described previously [23].the water molecule via this route may be important.
The protein was purified as previously described [27] with theFinally, it should be noted that the structure of the
following modifications: the initial ammonium sulfate fractionation
type II DHQase was solved in complex with 2,3-anhydro- step and the final heat treatment step were omitted. In particular the
quinic acid, which has a Ki of 30 M for this enzyme, final heat treatment step proved to be detrimental for crystallization
purposes. Protein was stored at 20C in 50 mM Tris-HCl (pH 7.5)20-fold lower than the Km for substrate. This transition
containing 30% glycerol.state analog has significant specificity for the type II
enzymes, as the Ki for the type I enzyme from Salmonella
typhimurium is 3 mM [25]. The presence of a molecule Crystallization and Data Collection
of tartrate and glycerol in the active site of the structure Protein was dialyzed overnight to remove glycerol and concentrated
to 10 mg/ml using Centricon-30 centrifugal concentrators (Amicon,(Figure 6C) was surprising and illustrates the available
Stonehouse, Gloucestershire, UK). Initial crystallization attemptsspace and functional groups to be exploited in future
were focused around the conditions previously published for theinhibitor design.
M. tuberculosis enzyme [30], but these yielded crystals that were
either twinned or dendritic in form. Successful crystals were ob-
Biological Implications tained from linear screens using various PEG and salt combinations
across a range of pHs. The crystals were morphologically of two
habits: the first was cubic in form, and the other was orthorhombic.The third reaction of the shikimate pathway is catalyzed
The cubic form crystals could only be indexed in a large cubic latticeby one of two structurally and mechanistically distinct
(of F or P Bravais type), but the data would not merge in any spaceenzymes: a type I or type II dehydroquinase (DHQase).
group higher than P1, so they were abandoned. Orthorhombic-
The enzymes of this pathway have been identified as shaped crystals grown from 20% PEG 8K and 0.2 M Li2SO4 in 0.1
potential antimicrobial targets, with DHQases offering M HEPES at pH 7.5 were found to diffract to better than 2.8 A˚
the possibility of targeting specific microbes. resolution at room temperature in house using a MacScience
DIP2000 detector. Data were integrated and scaled using the HKLThe crystal structures of native type II DHQase from
suite of programs [31]. The crystals were found to belong to theS. coelicolor, those in complex with the transition state
orthorhombic crystal system, with unit cell dimensions of a analog 2,3-anhydro-quinic acid and the competitive in-
117.2 A˚, b  138.7 A˚, and c  141.4 A˚. Analysis of the systematic
hibitor phosphate, and the catalytically compromised absences in the data revealed absences at h  2n, k  2n, and l 
R23A mutant in complex with the product dehydroshiki- 2n along the (h00), (0k0), and (00l) axes, respectively, which are
mate have been solved. These have allowed the defini- consistent with the space group P212121. From the Matthews calcu-
lation [32], assuming typical Vm between 1.6 and 4.0, we estimatedtion of the active site residues and the mode of substrate
that there were between 9 and 22 monomers in the asymmetric unit.binding. In addition, the lid domain (residues 21–31) not
As the biologically active form of the enzyme is a dodecamer, wevisible in the M. tuberculosis structure [15] has been
predicted that there were 12 monomers per asymmetric unit, giving
resolved in both open and closed conformations. a Vm of 2.9 A˚3 Da1, corresponding to a solvent content of 57.1%.
From these structures we are able to propose a mech- This data was used to initially solve the structure. Crystallization
anism involving the 1,2-anti elimination of H2O from conditions were optimized for each of the cocrystallization experi-
ments, with the best crystals being obtained with 0.1M Tris (pH 8.5)3-dehydroquinate to form 3-dehydroshikimate via an
and between 10% and 20% PEG 8K with 0.2 M of Na/K phosphateE1CB mechanism with an enol intermediate. We propose
(phosphate), 0.5 M MgCl2 (R23A mutant, apo-enzyme), and 0.2 Mthat Tyr28 performs the deprotonation of 3-dehydroqui-
Na Tartrate (2,3-anhydro-quinic acid) added.
nate as a result of a significantly reduced pKa arising High-resolution datasets were collected from DHQase apo-en-
from a basic environment formed by Arg113. The ab- zyme and cocrystallised with phosphate, 2,3-anhydro-quinic acid,
sence of any suitable residue to stabilize an enolate and an R23A mutant, DHQase with dehydroshikimate. The crystals
were loop mounted in a cryoprotectant containing either 17.5% (v/v)intermediate and the presence of a conserved active
glycerol or 20% MPD and cryocooled to 100 K using an Oxfordsite water molecule instead supports the reaction pro-
Cryosystems cryostream. Data were collected in 0.5 oscillationceeding via an enol intermediate. In the final step His106
frames on station 9.6 at the Daresbury SRS using the CCD (ADSC)
acts as the general acid to catalyze the elimination of Quantum 4 detector. The data were indexed and processed with
the C1 hydroxyl. the HKL suite [31]; the cell dimensions and space group are shown
This proposed mechanism and the structures re- in Table 1. Further processing was carried out using programs from
the CCP4 package [33].ported here offer the possibility for the rational design
of selective mechanism-based inhibitors of type II
DHQases based on 2,3-anhydro-quinic acid. These Molecular Replacement, Model Building, and Refinement
would block the shikimate pathway in pathogens such Molecular replacement was performed using the initial 2.8 A˚ data
as H. pylori and M. tuberculosis without affecting impor- collected in house. A dodecamer constructed using the M. tubercu-
losis structure [15] was used as the search model. The level oftant gut flora organisms, such as E. coli.
sequence identity between the two enzymes is 40%. The crossrota-
tion function and translation function were calculated using the dataExperimental Procedures
range of 10.0–4.0 A˚ in the standalone version of AMoRe [34]. Only
six solutions were greater than 50% of the maximum peak heightCloning, Sequencing, and Purification of DHQase
found in the rotation function, which were equivalent due to thefrom S. coelicolor
inherent symmetry of the search model. Correct translation functionThe N-terminal peptide of purified S. coelicolor DHQase [27] was
used to design an oligonucleotide, taking into account the codon solutions had correlation coefficients of 52.0 and R factors of 51.0.
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The solutions were subjected to rigid body refinement in AMoRe to pathways in filamentous fungi: theoretical and practical as-
pects. J. Gen. Microbiol. 139, 2891–2899.give a final correlation coefficient of 60% and an R-factor of 45.6%.
The resultant model was a full atomic model from the M. tubercu- 8. Shneier, A., Harris, J., Kleanthous, C., Coggins, J.R., Hawkins,
A.R., and Abell, C. (1993). Evidence for opposite stereochemicallosis enzyme; therefore, structure factors were calculated from this
model using SFALL, and then SIGMAA was used to calculate figures courses for the reactions catalyzed by type-I and type-II dehy-
droquinases. Bioorg. Med. Chem. Lett. 3, 1399–1402.of merit to prepare input for phase refinement using the program
DM [35]. Phase refinement included solvent flattening, histogram 9. Hanson, K.R., and Rose, I.A. (1963). The absolute stereochemi-
cal course of citric acid biosynthesis. Proc. Natl. Acad. Sci. USAmatching, and 12-fold noncrystallographic symmetry (NCS) averag-
ing. The averaged electron density map calculated using DM phases 50, 981–988.
10. Harris, J., Kleanthous, C., Coggins, J.R., Hawkins, A.R., andwas of excellent quality, allowing significant rebuilding of the struc-
ture using the program O [36]. Sulfate ions were found at the active Abell, C. (1993). Different mechanistic and stereochemical
courses for the reactions catalyzed by type-I and type-II dehy-site and on the NCS 3-fold axis. The measured reflections in the
range 30–2.8 A˚ with no sigma cutoff were used, excluding 10.0% droquinases. J. Chem. Soc. Chem. Commun. 13, 1080–1081.
11. Butler, J.R., Alworth, W.L., and Nugent, M.J. (1974). Mechanismrandomly distributed reflections to be used to calculate Rfree [37].
Rebuilding of the model was performed in the early stages using O of dehydroquinase catalysed dehydration. I. Formation of a
Schiff base intermediate. J. Am. Chem. Soc. 96, 1617–1618.and then subsequently using QUANTA (Molecular Simulations Inc.).
Refinement of the model was performed using a maximum likelihood 12. Chaudhuri, S., Duncan, K., Graham, L.D., and Coggins, J.R.
(1991). Identification of the active-site lysine residues of twomethod as implemented in REFMAC [38] using tight NCS restraints.
The model was refined to Rwork 17.0% and Rfree 21.7%. This model biosynthetic 3-dehydroquinases. Biochem. J. 275, 1–6.
13. Shneier, A., Kleanthous, C., Deka, R., Coggins, J.R., and Abell,was then used to phase the high-resolution data sets, extending the
existing Rfree set of reflections to the highest resolution. Rigid body C. (1991). Observation of an imine intermediate on dehydroqui-
nase by electrospray mass spectrometry. J. Am. Chem. Soc.refinement or molecular replacement methods were used to obtain
the starting model for each of the four structures. 113, 9416–9418.
14. Harris, J.M., Gonzalez-Bello, C., Kleanthous, C., Hawkins, A.R.,Refinement was carried out using REFMAC with at first tight and
then medium NCS restraints, and waters were added using ARP Coggins, J.R., and Abell, C. (1996). Evidence from kinetic iso-
tope studies for an enolate intermediate in the mechanism of[39] and QUANTA (Molecular Simulations Inc.). In the later stages
of refinement, the NCS restraints were removed, a fixed hydrogen type II dehydroquinases. Biochem. J. 319, 333–336.
15. Gourley, D.G., Shrive, A.K., Polikarpov, I., Krell, T., Coggins,atom contribution was added, and individual atom anisotropic tem-
perature factors were applied where appropriate [40]. The stereo- J.R., Hawkins, A.R., Isaacs, N.W., and Sawyer, L. (1999). The two
types of 3-dehydroquinase have distinct structures but catalyzechemical parameters, as determined using PROCHECK [41], were
either inside or better than expected for the respective structures. the same overall reaction. Nat. Struct. Biol. 6, 521–525.
16. Lo Conte, L., Ailey, B., Hubbard, T.J., Brenner, S.E., Murzin,There were two residues, Asn16 and Ala81, consistently in the gener-
ously allowed region; these were checked and found to be in con- A.G., and Chothia, C. (2000). SCOP: a structural classification
of proteins database. Nucleic Acids Res. 28, 257–259.vincing electron density in the structures. The final model statistics
are shown in Table 1. 17. Bottomley, J.R., Hawkins, A.R., and Kleanthous, C. (1996). Con-
formational changes and the role of metals in the mechanism
of type II dehydroquinase from Aspergillus nidulans. Biochem.Acknowledgments
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Accession Numbers
The coordinates for DHQase apo-enzyme, phosphate complex, 2,3-
anhydro-quinic acid complex, and R23A mutant DHS complex have
been deposited in the Protein Data Bank under accession codes
1GU0, 1D01, 1GU1, and 1GTZ, respectively.
